process

Neuroprotection

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Neuroprotection: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

303Connections

4Hypotheses

3Analyses

15Outgoing

50Incoming

No summary available yet. View on Wiki →

🧬 Biological Process Info

Name	Neuroprotection
Key Genes/Proteins	MT1, MT2, AKT, METALLOTHIONEIN, METALLOTHIONEIN-I+II
Related Pathways	Connexin43 Hemichannel Blockade, Cerebral Insulin Signaling
Linked Hypotheses	4 hypotheses

Wiki Pages (20)

Knowledge base pages for this entity

Pathway Diagram

graph TD
    Neuroprotection["Neuroprotection"] -->|"protects against"| Glaucoma["Glaucoma"]
    style Glaucoma fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    Neuroprotection["Neuroprotection"] -->|"protects against"| Neurodegeneration["Neurodegeneration"]
    style Neurodegeneration fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
    Neuroprotection["Neuroprotection"] -->|"protects against"| Axonal_Damage["Axonal Damage"]
    style Axonal_Damage fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
    Connexin43_Hemichannel_Blockad["Connexin43 Hemichannel Blockade"] -->|"mediates"| Neuroprotection["Neuroprotection"]
    style Connexin43_Hemichannel_Blockad fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    MT1["MT1"] -->|"involved in"| Neuroprotection["Neuroprotection"]
    style MT1 fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    MT2["MT2"] -->|"involved in"| Neuroprotection["Neuroprotection"]
    style MT2 fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    Tudca["Tudca"] -->|"mediates"| Neuroprotection["Neuroprotection"]
    style Tudca fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    AKT["AKT"] -->|"involved in"| Neuroprotection["Neuroprotection"]
    style AKT fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    style Neuroprotection fill:#5d4400,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold

Outgoing (31)

Target	Relation	Type	Str
Glaucoma	protects_against	disease	0.85
Neurodegeneration	protects_against	process	0.85
Axonal Damage	protects_against	phenotype	0.85
CENTRAL NERVOUS SYSTEM	protects_against	concept	0.50
GLIOSIS	activates	concept	0.50
CENTRAL NERVOUS SYSTEM	activates	concept	0.50
ISCHEMIC STROKE	protects_against	concept	0.50
ISCHEMIC STROKE	inhibits	concept	0.50
MAPK SIGNALING	activates	concept	0.50
REMYELINATION	inhibits	concept	0.50
IGF-1	activates	concept	0.50
ISCHEMIC STROKE	activates	concept	0.50
MICROGLIAL ACTIVATION	activates	concept	0.50
QUERCETIN	interacts_with	concept	0.50
PI3K/AKT SIGNALING	activates	concept	0.50

Incoming (272)

Source	Relation	Type	Str
Connexin43 Hemichannel Blockade	mediates	mechanism	0.95
MT1	involved_in	protein	0.95
MT2	involved_in	protein	0.95
Tudca	mediates	compound	0.95
AKT	involved_in	protein	0.95
METALLOTHIONEIN	mediates	protein	0.95
METALLOTHIONEIN-I+II	involved_in	protein	0.95
Microglia	mediates	cell_type	0.90
Cerebral Insulin Signaling	mediates	pathway	0.90
Connexin43 Hemichannel Blockade	activates	mechanism	0.90
Gd3 Synthase	mediates	enzyme	0.90
Berberine-Inspired Ionizable Lipid	promotes	compound	0.90
Methylene Blue	promotes	drug	0.90
TGR5	mediates	receptor	0.90
Astrocytes	mediates	cell_type	0.90
NO	mediates	compound	0.90
GJA1	modulates	protein	0.90
INTESTINAL NHR-86	mediates	protein	0.90
APOE4	suppresses	gene	0.88
Hk2-Pink1 Pathway	mediates	pathway	0.88
PRKN	mediates	protein	0.85
AMPK	mediates	protein	0.85
Mitochondrial Homeostasis	involved_in	process	0.85
Tryptophan Metabolites	mediates	compound	0.85
APOE Ε4	inhibits	protein	0.85
NFE2L2	mediates	gene	0.85
Polyphenols	mediates	compound	0.85
Antioxidant Enzymatic Systems	involved_in	pathway	0.85
A2 Astrocytes	mediates	cell_type	0.85
Macrophage/Microglia Autophagy	protects_against	process	0.85
MAPK Signaling Pathway	mediates	pathway	0.85
MicroRNAs	mediates	biomarker	0.85
Long Non-Coding RNAs	mediates	biomarker	0.85
lncRNAs	mediates	biomarker	0.85
HDAC3 Inhibition	mediates	mechanism	0.85
BDNF	promotes	gene	0.85
Parkin Phosphorylation	mediates	mechanism	0.85
PPARGC1A	mediates	gene	0.85
Astrocytes	involved_in	cell_type	0.85
STING Inhibition	protects_against	mechanism	0.85
BDNF	mediates	gene	0.85
Pi3K/Akt Pathway	mediates	pathway	0.85
Exosome-Based Treatments	promotes	drug	0.85
Nad	mediates	compound	0.80
Functional Mitochondria	mediates	compound	0.80
Phytochemicals	involved_in	compound	0.80
Urolithin A	mediates	compound	0.80
GLP-1R Agonists	mediates	drug	0.80
Gastrodin	mediates	compound	0.80
TET2 Upregulation	mediates	process	0.80

Targeting Hypotheses (4)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
DAPK1 Inhibition as Dual-Mechanism Neuroprotection Against T	0.579	neurodegeneration	Should microtubule-stabilizing drugs be
Ferroptosis Inhibition for α-Synuclein Neuroprotection	0.548	neurodegeneration	Gene expression changes in aging mouse b
Mitochondrial Biogenesis Rate as a Dynamic Biomarker of Neur	0.435	translational neuroscience	Which metabolic biomarkers can distingui
Microbiome-Derived Tryptophan Metabolite Neuroprotection	0.408	neurodegeneration	What are the mechanisms by which gut mic

Mentioning Analyses (3)

Scientific analyses that reference this entity

What molecular mechanisms underlie Atremorine's dramatic dopamine enhancement in

neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.467

Do P2RX7 antagonists selectively block pathogenic exosomes while preserving bene

neurodegeneration | 2026-04-11 | 0 hypotheses

Do APOE4-driven senescent astrocytes cause neurodegeneration or represent a prot

neurodegeneration | 2026-04-06 | 0 hypotheses

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year
Targeting the SCP2/HSPB1 Axis: A Novel Mechanism Underlying Ferroptosis Regulati [PMID:40993092]	Jiang H, Hu W, Yuan L	Tohoku J Exp Med	2026
GPX4 promotes optic nerve regeneration and retinal ganglion cell neuroprotection [PMID:41485051]	Yang M, Bian F, Feng X, Li L, Huang H et	Mol Ther	2026
Extracellular GPX4 impairs antitumor immunity via dendritic ZP3 receptors. [PMID:41494530]	Liu J, Cai X, Lin J, Zhang Z, Zhou Q et	Cell	2026
Aging at the Crossroads of Cuproptosis and Ferroptosis: From Molecular Pathways [PMID:41516398]	Gromadzka G, Tarnacka B, Cieślik M	Int J Mol Sci	2026
Ferroptosis in neurological diseases: moving towards therapeutic intervention. [PMID:41554903]	Tuo QZ, Bush AI, Lei P	Mol Psychiatry	2026
Fin(e)-tuning ferroptosis. [PMID:41576911]	Szylo KJ, Dixon SJ	Mol Cell	2026
GPX4-dependent ferroptosis governs ILC2 homeostasis and colitis progression. [PMID:41663525]	Liu G, Wang Y, Huang H, Wang J, Yang J e	Cell Mol Immunol	2026
A GPX1-OSBPL8 axis mediates noncanonical in vivo ferroptosis and cancer growth s [PMID:41720096]	Xia Z, Yang X, Samovich SN, Tyurina YY,	Cell	2026
The crossroads of inflammation and oxidative stress: A review of the interplay b [PMID:41722697]	Park WH	Pharmacol Res	2026
Ferroptosis in Cerebral Ischemia/Reperfusion Injury: Mechanistic Drivers and The [PMID:41738060]	Song C, Liu Z, Tang J, Huang Y	Neuropsychiatr Dis Treat	2026
Decoding GPX4 regulation in ferroptosis: mechanisms and therapeutic implications [PMID:41826143]	Chen X	Trends Mol Med	2026
4-Octyl itaconate attenuates radiation-induced intestinal injury associated with [PMID:41936917]	Zhang S, Yue T, Jin P, Zhang X, Huo Q et	Free Radic Biol Med	2026
Di-2-ethylhexylphthalate-induced miR155-5P promotes placental ferroptosis. [PMID:41937013]	Gu X, Sun F, Li Y, Yang S, Li Y	Int J Biol Macromol	2026
Co-Delivery of Ferrostatin-1 and M2 Macrophage-Derived Exosomal Signals via Engi [PMID:41944411]	Hao W, Sun N, Xue R, Chang J, Pang X et	ACS Appl Mater Interfaces	2026
Hyperlipidemia Aggravates Alveolar Bone Loss via Periodontal Ligament Stem Cell [PMID:41945797]	Zhang Y, Wang X, Wu Y, Liu L, Nuerlan G	Adv Sci (Weinh)	2026
Ferroptosis-related mechanisms in prion diseases provide insights into neurodege [PMID:41945998]	Zayed M, Tayara H, Jeong BH	Redox Biol	2026
[The Chinese medicine Gandouling attenuates brain injury in hepatolenticular deg [PMID:41946579]	Wu K, Wang N, Zhao D, Wei W, Zhang W et	Zhejiang Da Xue Xue Bao Yi Xue	2026
Isorhamnetin-preconditioned MSC-derived exosomes restore ovarian function by inh [PMID:41947243]	Zhang Q, Yu J, Zheng Y, Jiang J, Zheng L	Stem Cell Res Ther	2026
NOX4 mediates ferroptosis through oxidative stress in diabetic keratopathy. [PMID:41951167]	Wang X, Wang Y, Zhao X, Yu X, Qu Y et al	Exp Eye Res	2026
Targeting NDUFS4 Disrupts Oxidative Phosphorylation and Induces Ferroptosis in O [PMID:41954274]	Schaaf ZA, Ning S, Leslie AR, Sharifi M,	Mol Cancer Ther	2026

Neuroprotection

Understanding Entity Pages

Wiki Pages (20)

cbs-psp-daily-action-plan

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

Clinical Management Guide for CBS/PSP

Progressive Supranuclear Palsy (PSP)

Corticobasal Syndrome (CBS)

Novel Therapy Index

Parkinson's Disease

Sleep and Circadian Dysfunction in Alzheimer's Disease

Microglia CD8+ T Cell Recruitment -- Supplementary WW Content

primary-progressive-aphasia

CBS/PSP Supplements Guide

Atypical Parkinsonism

Device Therapies Comparison for CBS/PSP

Parthanatos in Neurodegeneration

CBS/PSP Rehabilitation Master Guide

calcium-dysregulation-comparison

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

Alpha-Synuclein Pathology

PD Combination Therapy Matrix

Corticobasal Degeneration (CBD)